🇺🇸 FDA
Pipeline program

Chlorid sodný B. Braun 0,9 % infuzní roztok, DUOFAG

DUO2022_01

Phase 2 small_molecule active

Quick answer

Chlorid sodný B. Braun 0,9 % infuzní roztok, DUOFAG for Surgical wound infection/dehiscence caused by S. aureus and/or P. aeruginosa colonization is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Surgical wound infection/dehiscence caused by S. aureus and/or P. aeruginosa colonization
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials